Stronger Sell Today RARX ranks #4810 as SELL CANDIDATE. Weaker Sell
Today RARX ranks #4810 as SELL CANDIDATE.

RARX stock Ra Pharmaceuticals Inc

RARX stock
Ra Pharmaceuticals Inc

April 24, 2019
Change -1.41%
Chart period: 2019-01-25 - 2019-04-24
VOLUME
Buy
TREND
Buy

MV LONG
Sell

MV SHORT
Buy

PIVOT
Sell

MACD
Buy

Will RARX stock price go up or down on Fri, 26 Apr 2019?

Ra Pharmaceuticals Inc Forecast and Stock Analysis

Technical RARX stock analysis for April 24, 2019.

Sell candidate since 2019-04-23 Loss -1.41%
Shorts n/a
Cash n/a
Loans n/a
Beta 0.78
ROA -43.88

Ra Pharmaceuticals Inc fell by -1.41% in the last day from $21.96 to $21.65 The price has fallen in 8 of the last 10 days and is down by -8.46% for this period. Volume has increased in the last day by 109 166 shares, but on falling prices. This may be an early warning and the risk will be increased slightly for the next couple of days. In total, 414 662 shares bought and sold for approximately $8.98 million.

Close price at the end of the last trading day (Wednesday, 24th Apr 2019) of the RARX stock was $21.65. This is 1.41% less than the trading day before Tuesday, 23rd Apr 2019.

During day the stock fluctuated 4.31% from a day low at $21.35 to a day high of $22.27.

30 day high of the RARX stock price was $24.49 and low was $20.19.
90 day high was $27.68 and low was $18.06.
52 week high for the Ra Pharmaceuticals Inc - $27.68 and low - $5.64.

Trend

Ra Pharmaceuticals Inc lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 14.48% during the next 3 months and, with 90% probability hold a price between $21.97 and $33.01 at the end of this period.

Click here for today's Top 5 Trending Companies

Signals

There are few to none technical positive signals at the moment. Ra Pharmaceuticals Inc holds a buysignal from the short-term moving average; at the same time, however, a sales signal from the long-term average. Since the longterm average is above the short-term average there is a general sales signal in the stock. On further gains, the stock will meet resistance from the long-term moving average at $23.40. On a fall, the stock will find some support from the short-term average at $21.57. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sales signal and strengthen the general signal. A sales signal was issued from a pivot top point on Tuesday April 23, 2019, which indicates further falls until a new bottom pivot has been found. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Access today's Top 5 Golden Star Companies

Relative Strength Index (RSI)

RSI14 is 45 and the stock is currently not being overbought or oversold

Access full RSI 14 and RSI 21 lists

Support & Resistance

Ra Pharmaceuticals Inc finds support from accumulated volume at $20.88.

Support: $20.88 Price: $21.65 Resistance: $21.92

Risk

This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.92 between high and low, or 4.31%. For the last week, the stock has had a daily average volatility of 5.83%.

Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.

Overall risk:

Very Low Low Medium High Very High

Stronger Sell Today RARX ranks #4810 as SELL CANDIDATE. Weaker Sell
Today RARX ranks #4810 as SELL CANDIDATE.